Clinical Trials Arena January 23, 2026
While sponsors are looking to integrate AI into their trials, fixing the core issues is vital, experts say.
Trial acceleration has been a topic of conversation for the pharmaceutical sector for years and as technology advances, it is becoming even more of a reality. The time that artificial intelligence (AI) can save sponsors and sites makes it easier than ever to reduce trial timelines; however, the technology will only work well if foundations are strong.
AI is being used to help with site selection, data management and more in the early stages of protocol planning, but cannot replace the basics that should be in place to ensure trials run smoothly. This means that issues need to be addressed which impact...
Today's Sponsors
Today's Sponsor